Page last updated: 2024-09-04

febuxostat and Diffuse Mixed Small and Large Cell Lymphoma

febuxostat has been researched along with Diffuse Mixed Small and Large Cell Lymphoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Horii, M; Kobayashi, S; Kurokawa, Y; Yasu, T	1

Other Studies

1 other study(ies) available for febuxostat and Diffuse Mixed Small and Large Cell Lymphoma

Article	Year
The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma . International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Tumor Lysis Syndrome	2016

Article

Year

The efficacy of febuxostat 10 mg for the prevention of hyperuricemia associated with tumor lysis syndrome (TLS) in Japanese patients with non-Hodgkin's lymphoma .

International journal of clinical pharmacology and therapeutics, 2016, Volume: 54, Issue:12

Topics: Adult; Aged; Aged, 80 and over; Febuxostat; Female; Gout Suppressants; Humans; Hyperuricemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Retrospective Studies; Tumor Lysis Syndrome

2016